Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Xu Zhang PhD"'
Publikováno v:
Integrative Cancer Therapies, Vol 21 (2022)
Background: Skin rash is the most common adverse effect associated with epidermal growth factor receptor inhibitors (EGFRIs). The study has observed the efficacy and safety of Zhiyang Pingfu Liquid in the treatment of EGFRIs-related moderate and seve
Externí odkaz:
https://doaj.org/article/a08179b3b19c4f07b96889048dbc50b2
Autor:
Shiping Zhang1,2, Hongxiao Li1, Liqiu Li1, Qian Gao1, Ling Gu1, Cheng Hu1, Meijuan Chen1, Xu Zhang1 zhangxu@njucm.edu.cn
Publikováno v:
Journal of Cancer. 2024, Vol. 15 Issue 12, p3939-3942. 4p.
Publikováno v:
Journal of Cancer. 2024, Vol. 15 Issue 13, p4095-4096. 2p.
Autor:
Ping Zhou
Publikováno v:
Frontiers in Rehabilitation Sciences; 2024, p1-4, 4p
Publikováno v:
Journal of Burn Care & Research; 2023 Supplement, Vol. 44, pS1-S176, 176p
Autor:
Lee, Linden O., Ramirez-Chapman, Ana Lisa, White, Danielle L., Zhang, Xu, Lu, Monica, Suresh, Maya S.
Publikováno v:
Anesthesia & Analgesia; Jan2023, Vol. 136 Issue 1, p86-93, 8p
Publikováno v:
Journal of Vinyl & Additive Technology; Nov2022, Vol. 28 Issue 4, p855-864, 10p
Autor:
Xu Zhang1 xu.zhang@plymouth.ac.uk
Publikováno v:
Global Studies Journal. Sep2017, Vol. 10 Issue 3, p19-26. 8p.
Publikováno v:
Science & Technology for the Built Environment. Feb/Mar2017, Vol. 23 Issue 2, p251-263. 13p.
Autor:
Ma, Ke, Yang, Jie, Shao, Yihui, Li, Ping, Guo, Hongchang, Wu, Jianing, Zhu, Yi, Zhang, Hui, Zhang, Xu, Du, Jie, Li, Yulin
Publikováno v:
Circulation Research; 4/1/2022, Vol. 130 Issue 7, p1056-1071, 16p